Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoromethane SCHEMBL28248919 | 0.96 | CYP1A2 (0.47) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL9083407 | 0.86 | CYP1A2 (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL9816382 | 0.86 | CYP1A2 (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL29266181 | 0.85 | GAA (0.60) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL27768067 | 0.84 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL22780 | 0.84 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL6178625 | 0.83 | GAA (0.52) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL8879326 | 0.83 | GAA (0.54) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL28197993 | 0.82 | GAA (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL4324913 | 0.82 | GAA (0.63) | GAAMGAMSIMGAM2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11440920-B2 | Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method | SHOWA UNIVERSITY (JP) | 2022-09-13 | — | — | US | claimed |
| CN-113773438-B | Carbon dioxide thickener for medium-high permeability oil reservoir and preparation method and technology thereof | 德仕能源科技集团股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-113773438-A | Carbon dioxide thickener for medium-high permeability oil reservoir and preparation method and technology thereof | 德仕能源科技集团股份有限公司 | 2021-12-10 | — | — | CN | claimed |
| US-20200140450-A1 | CHEMICAL METHOD OF PRODUCING SMTP GROUPS OR SMTP-7 AND INTERMEDIATES USED IN THE METHOD | SHOWA UNIVERSITY (JP) | 2020-05-07 | — | — | US | claimed |
| US-7615650-B2 | Process for producing chroman compound | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-11-10 | — | — | US | claimed |
| US-20070179304-A1 | Process for producing chroman compound | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-08-02 | — | — | US | claimed |
| EP-3882252-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025224262-A1 | COMBINATION THERAPIES COMPRISING A CDK2 DEGRADER AND A CDK4/6 INHIBITOR | MONTE ROSA THERAPEUTICS AG (CH) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025224249-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2025-10-30 | — | — | WO | disclosed |
| EP-4608816-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | Monte Rosa Therapeutics AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-20250263395-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-21 | — | — | US | disclosed |
| CN-119039195-A | Preparation method of beta-thiocyanate alcohol derivative | 山东省分析测试中心 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024092039-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| EP-0294229-B1 | NOVEL HETEROCYCLIC PESTICIDAL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-12-02 | — | — | EP | disclosed |
| EP-0294229-A2 | Novel heterocyclic pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-12-07 | — | — | EP | disclosed |
| US-4786750-A | Pentene derivatives | ICI AMERICAS INC. (US) | 1988-11-22 | — | — | US | disclosed |
| US-4709063-A | Preparation of 2-halo-5-methylpyridines from 4-methyl-4-pentene derivatives | ICI AMERICAS INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4628096-A | Preparation of 2-halo-5-methylpyridines from 4-methyl-4-pentene derivatives | ICI AMERICAS INC. (US) | 1986-12-09 | — | — | US | disclosed |
| US-4504664-A | 2-Piperidones | ICI AMERICAS INC. (US) | 1985-03-12 | — | — | US | disclosed |
| US-4234741-A | BENZENESELENYL HALIDE REACTANT, SELENIUM-CONTAINING INTERMEDIATES | FIRMENICH, S.A. (CH) | 1980-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140450-A1 | CHEMICAL METHOD OF PRODUCING SMTP GROUPS OR SMTP-7 AND INTERMEDIATES USED IN THE METHOD | TST, SMS, TMSB4X | GAA 3536/4885MGAM 4507/4885SI 618/4885 |
| US-20070179304-A1 | Process for producing chroman compound | TAF9, TAF1, CHD1 | GAA 488/4885MGAM 847/4885SI 737/4885 |
| US-11440920-B2 | Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method | SMS, TST, TES | GAA 2241/4885MGAM 3700/4885SI 244/4885 |
| US-20250263395-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | CDK2, SKP2, CDK1 | GAA 2291/4885MGAM 3000/4885SI 3055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.